These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9751159)

  • 1. Mesolimbic dopaminergic mechanisms underlying individual differences in sugar consumption and amphetamine hyperlocomotion in Wistar rats.
    Sills TL; Onalaja AO; Crawley JN
    Eur J Neurosci; 1998 May; 10(5):1895-902. PubMed ID: 9751159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS; Jones DN; Holtzman SG; Juncos JL; Kalivas PW; Justice JB
    Psychopharmacology (Berl); 1994 Oct; 116(2):217-25. PubMed ID: 7862951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens.
    Sills TL; Crawley JN
    Eur J Pharmacol; 1996 May; 303(3):177-81. PubMed ID: 8813564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphetamine challenge on local cerebral glucose utilization after chronic dopamine D1 and D2 receptor agonist administration to rats.
    Huang YH; Tsai SJ; Huang HJ; Sim CB
    Eur J Pharmacol; 1997 Nov; 338(2):117-21. PubMed ID: 9455992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.
    Essman WD; McGonigle P; Lucki I
    Psychopharmacology (Berl); 1993; 112(2-3):233-41. PubMed ID: 7871025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
    Harvey J; Lacey MG
    J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice.
    Smith DG; Tzavara ET; Shaw J; Luecke S; Wade M; Davis R; Salhoff C; Nomikos GG; Gehlert DR
    J Neurosci; 2005 Jan; 25(4):914-22. PubMed ID: 15673672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine in prepulse inhibition of acoustic startle.
    Zhang J; Forkstam C; Engel JA; Svensson L
    Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.
    Wan RQ; Corbett R
    Neuropsychopharmacology; 1997 Apr; 16(4):259-68. PubMed ID: 9094143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
    Kuczenski R; Segal DS
    Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Dalia A; Uretsky NJ; Wallace LJ
    Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.